Investing in a Carcinogen-Free Future

HealBac is bridging the gap between deep-tech biotechnology and the $4.2B global food preservative market.

The Opportunity

Capturing the Beachhead in Processed Meats

Manufacturers are caught in a regulatory squeeze. Consumers demand clean labels, but safety requires preservatives. Our first-to-market solution, Freshness Bioguard™, solves this paradox at half the cost of existing nitrite alternatives.

$4.2B

Total Addressable Market

Cost Competitiveness

Beachhead Strategy

1
Processed Meats (Sausage/Bacon/Ham) - Replacement of Nitrites
2
Bakery, Dairy & Beverages - Replacement of chemical preservatives like sorbates and benzoates
3
Personal Care - Antibacterial Skin Care via Extracellular Vesicles (EVs) and Conditioned media (CM)

Investment Highlights

Bridging scientific excellence with commercial disruption.

Regulatory Tailwinds

Global nitrite limitations are forcing rapid reformulation; the food industry is actively seeking safe, non-carcinogenic alternatives to meet new safety standards.

Differentiated Science

Nature-inspired AMPs identified from primed fat cells; backed by strong preclinical data and industry-leading antibiofilm performance.

Commercial Traction

Four paid pilots completed with first revenue booked; established manufacturing partnerships in Singapore, India, US, and China.

Compelling Economics

Ingredient cost ~US$0.007/kg meat—2× cheaper than HPP and highly competitive with traditional nitrites at commercial scale.

Strong IP Moat

Exclusive licensing and multiple patent applications covering novel peptide sequences and adipose-cell activation methods.

Revenue Potential

Revenue Projection: $36M by 2032 Targeting a sustainable Gross Margin of 90% through scalable biotech producti

Roadmap to Series A

Pilot Expansion
Current Phase
Onboarding 5 major APAC meat manufacturers and finalizing CMO scale-up in Singapore/India.
Pilot Expansion
Regulatory Milestone
Submission of FDA GRAS and SFA safety dossiers for Freshness Bioguard™.
Regulatory Milestone
Global Launch
Full commercial rollout in Singapore followed by expansion into the US and EU markets.
Global Launch

Join our Seed Round

We are currently raising our Seed round of 1 M USD to accelerate regulatory clearance and pilot scale-up. Contact our CEO for a private briefing.

Authorized professional investors only.